Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hpsc-CMS

Ended Project Grant Awarded Last action

Award ID
R44HL151094
Recipient
Awarding agency
Obligated
$6,159,008

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $5,409,008.00 Federal
  • $750,000.00 Non-federal
Place of performance
Washington, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $169,156 $0
Amendment $169,156 $0
Amendment $242,088 $0
Amendment $242,088 $0
Amendment $242,088 $0
Amendment $750,000 $0
Amendment $750,000 $0
Amendment $750,000 $0
Amendment $38,243 $0
Amendment -$38,243 $0
Amendment -$38,243 $0
Amendment $38,243 $0
Amendment -$38,243 $0
Amendment $38,243 $0
Amendment $123,144 $0
Amendment $123,144 $0
Amendment $123,144 $0
Amendment $750,000 $0
Amendment $750,000 $750,000
Original award $225,000 $0
Show all 21

Quick answers

Who received award R44HL151094?

R44HL151094 was awarded to Curi Bio Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2020.

How much is award R44HL151094 worth?

$6,159,008 has been obligated on R44HL151094: $5,409,008 in federal funding and $750,000 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award